Connect with us
BioNTech shares are off to a strong start in 2026, gaining over 21 percent in both European and U.S. markets. Analysts remain optimistic, with most recommending...
Biotech stocks are currently out of favor, but analysts believe sentiment may have bottomed out, creating a buying opportunity—especially for undervalued small and mid-cap firms. Concerns...
Global markets saw mixed performances: DAX fell 0.6% to 19,909 points, pressured by BASF, BMW, and Bayer. MDAX and TecDAX also dropped. Hang Seng gained 0.7%,...
The biotech sector was one of the sectors which developed strongly thanks to the pandemic. Biotech companies were in the spotlight of the investors and everyone...
More and more people are getting cancer. In Germany alone, doctors diagnose around half a million new cancer patients every year. But science is also making...
Biotechnology is an exciting field that works with biology to develop new enhancements in medicine and science. Because of its broad reach, it comes as no...
The biotech industry is a lucrative business with a focus on curing people. Biotechnology’s development of drugs to treat diseases comes with risks but also with...